Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fruit Development, Structure, and Function01:58

Fruit Development, Structure, and Function

25.3K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.3K
Seed Structure and Early Development of the Sporophyte02:33

Seed Structure and Early Development of the Sporophyte

31.2K
Seed structures are composed of a protective seed coat surrounding a plant embryo, and a food store for the developing embryo. The embryo contains the precursor tissues for leaves, stem, and roots. The endosperm and cotyledons—seed leaves—act as the food reserves for the growing embryo.
31.2K
Strategies of Self-Presentation I: Strategic Self-Presentation01:12

Strategies of Self-Presentation I: Strategic Self-Presentation

220
Strategic self-presentation refers to individuals' intentional efforts to influence how others perceive them. This process is employed in various social and professional settings, such as job interviews, dating, politics, and legal contexts, where individuals seek to shape impressions to gain social or material advantages. While people generally present themselves in ways that align with their authentic characteristics, external factors, such as cognitive load, can hinder their ability to...
220
The Uncertainty Principle04:08

The Uncertainty Principle

31.9K
Werner Heisenberg considered the limits of how accurately one can measure properties of an electron or other microscopic particles. He determined that there is a fundamental limit to how accurately one can measure both a particle’s position and its momentum simultaneously. The more accurate the measurement of the momentum of a particle is known, the less accurate the position at that time is known and vice versa. This is what is now called the Heisenberg uncertainty principle. He...
31.9K
Hardy-Weinberg Principle01:49

Hardy-Weinberg Principle

76.4K
Diploid organisms have two alleles of each gene, one from each parent, in their somatic cells. Therefore, each individual contributes two alleles to the gene pool of the population. The gene pool of a population is the sum of every allele of all genes within that population and has some degree of variation. Genetic variation is typically expressed as a relative frequency, which is the percentage of the total population that has a given allele, genotype or phenotype.
76.4K
The Pauli Exclusion Principle03:06

The Pauli Exclusion Principle

59.4K
The arrangement of electrons in the orbitals of an atom is called its electron configuration. We describe an electron configuration with a symbol that contains three pieces of information:
59.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ADAM9: an updated view of its biology and pathology.

Molecular biology reports·2026
Same author

Strategic adoption of model-informed drug development (MIDD) as an overarching business model in biotechnology and life science industry.

Drug discovery today·2026
Same author

Beyond Impossibility: Reimagining Clinical Evidence for Children with Ultra-Rare Diseases.

Journal of clinical pharmacology·2026
Same author

Invisible No More: How Redefining Rare Diseases Can Advance Health Equity.

Journal of clinical pharmacology·2026
Same author

Has Pharmacologic Contextualization Become a Lost Art? How Can We Revive the Integrator Pharmacologist?

Journal of clinical pharmacology·2025
Same author

US FDA's Strategic Transition of Animal to Non-Animal Alternatives for Monoclonal Antibody Development: A Much Needed Fuel to Incentivize Innovation.

Journal of clinical pharmacology·2025
Same journal

Different Clinical Questions Need Different Estimands.

Therapeutic innovation & regulatory science·2026
Same journal

Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.

Therapeutic innovation & regulatory science·2026
Same journal

Understanding the Added Value of Action Limits for QTL Monitoring.

Therapeutic innovation & regulatory science·2026
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.6K

Principled Structured Incorporation of Clinical Knowledge Into Strategic Development Decisions.

A Lawrence Gould1, Rajesh Krishna2, Anis Khan3

  • 11 Merck Research Laboratories, West Point, PA, USA.

Therapeutic Innovation & Regulatory Science
|September 18, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces a quantitative method for pharmaceutical development decisions. It objectively assesses evidence using pairwise comparisons to guide resource allocation and project progression, enhancing decision-making efficiency.

Keywords:
analytic hierarchy processrandomized preferencesrisk evaluationstatistical decision

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
The Modified Temptation Resistance Task: A Paradigm to Elicit Children's Strategic Lie-telling
06:51

The Modified Temptation Resistance Task: A Paradigm to Elicit Children's Strategic Lie-telling

Published on: April 6, 2018

8.9K

Related Experiment Videos

Last Updated: Feb 5, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.6K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K
The Modified Temptation Resistance Task: A Paradigm to Elicit Children's Strategic Lie-telling
06:51

The Modified Temptation Resistance Task: A Paradigm to Elicit Children's Strategic Lie-telling

Published on: April 6, 2018

8.9K

Area of Science:

  • Pharmaceutical Science
  • Decision Analysis
  • Biostatistics

Background:

  • Efficient pharmaceutical product development necessitates integrating multiple attributes like efficacy and safety.
  • Current decision-making processes can be improved by transparently integrating team expertise with experimental findings.

Purpose of the Study:

  • To present a quantitative and objective approach for assessing evidence throughout pharmaceutical product development.
  • To enable more effective resource allocation and decision-making regarding project progression or termination.

Main Methods:

  • Developing a mathematical framework that combines sets of pairwise comparisons.
  • Defining process attributes and decision rules collaboratively with project teams and stakeholders prior to data collection.
  • Utilizing standard statistical decision analysis methods to evaluate the approach's properties.

Main Results:

  • The proposed method allows for quantitative and objective evidence assessment at any development stage.
  • Pre-defined decision rules enhance the sensitivity analysis of recommended actions based on various assumptions.
  • The approach facilitates reproducible integration of knowledge and experimental data.

Conclusions:

  • This quantitative method offers a robust framework for optimizing pharmaceutical product development decisions.
  • It promotes transparency, objectivity, and efficiency in resource management by systematically evaluating project evidence.
  • The approach is adaptable and statistically sound, supporting informed decision-making throughout the drug development lifecycle.